FDA/CDC
FDA/CDC
FDA OKs Pfizer COVID booster for 65 and over, those at high risk
Emerging evidence shows that booster doses of the Pfizer vaccine cause front-line immune defenders — called binding antibodies — to roughly triple...
FDA/CDC
FDA panel backs Pfizer's COVID booster for 65 and older, those at high risk
This followed an earlier 16-2 vote by the panel rejecting a booster dose for Americans age 16 and over.
Latest News
New Moderna vaccine data ‘support’ booster shot after 8 months
There is still a lot of debate in the medical community about the need for boosters.
FDA/CDC
Flu and COVID-19 vaccines can be given on the same day: CDC and AAP
“Extensive experience with non–COVID-19 vaccines has demonstrated that immunogenicity and adverse-event profiles are generally similar.”
FDA/CDC
FDA moves to block some vape products, delays action on Juul
The American Cancer Society and other advocacy groups slammed the FDA’s decision to withhold action on major e-cigarette manufacturers, including...
Latest News
FDA inaction on hair loss drug’s suicide, depression, erectile dysfunction risk sparks lawsuit
As an alternative, PFSF requested that the FDA require the drug’s manufacturers revise the safety information on the labeling and add boxed...
FDA/CDC
FDA OKs IV Briviact for seizures in kids as young as 1 month
The approval marks the first time that the IV formulation will be available for children.
FDA/CDC
FDA okays difelikefalin for dialysis-associated pruritus in patients with CKD
Pruritus in patients with chronic kidney disease on hemodialysis is common and has had no widely accepted go-to treatment.
FDA/CDC
Empagliflozin gets HFrEF approval from FDA
The SGLT2 inhibitor empagliflozin (Jardiance) becomes the second agent from this class to get a heart failure indication regardless of diabetes...
FDA/CDC
FDA OKs stimulation device for anxiety in depression
The neurostimulation system has previously received FDA approval for refractory depression, obsessive-compulsive disorder, and smoking addiction...